Literature DB >> 16929246

Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study.

B M van Gelder1, B Buijsse, M Tijhuis, S Kalmijn, S Giampaoli, A Nissinen, D Kromhout.   

Abstract

OBJECTIVE: To investigate whether coffee consumption is associated with 10-year cognitive decline in elderly men, as results of previous studies obtained hitherto have been controversial and prospective information on this association has been lacking. DESIGN, SUBJECTS AND
SETTING: Six hundred and seventy six healthy men born between 1900 and 1920 from Finland, Italy and the Netherlands participated in a 10-year prospective cohort study. Cognitive functioning was assessed using the Mini-Mental State Examination (0-30 points, with a higher score indicating better cognitive performance). Coffee consumption was estimated in cups per day. A mixed longitudinal model was used to investigate the association between baseline coffee consumption and 10-year cognitive decline. Multiple adjustments were made.
RESULTS: Men who consumed coffee had a 10-year cognitive decline of 1.2 points (4%). Non-consumers had an additional decline of 1.4 points (P<0.001). An inverse and J-shaped association was observed between the number of cups of coffee consumed and cognitive decline, with the least cognitive decline for three cups of coffee per day (0.6 points). This decline was 4.3 times smaller than the decline of non-consumers (P<0.001).
CONCLUSIONS: Findings suggest that consuming coffee reduces cognitive decline in elderly men. An inverse and J-shaped association may exist between the number of cups of coffee consumed and cognitive decline, with the least cognitive decline for men consuming three cups of coffee per day.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929246     DOI: 10.1038/sj.ejcn.1602495

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  63 in total

1.  Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.

Authors:  Hisham Qosa; Alaa H Abuznait; Ronald A Hill; Amal Kaddoumi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  [Coffee and mental health].

Authors:  Rafael Franco
Journal:  Aten Primaria       Date:  2009-09-10       Impact factor: 1.137

Review 3.  Caffeine and the control of cerebral hemodynamics.

Authors:  Dale A Pelligrino; Hao-Liang Xu; Francesco Vetri
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  The neuroprotective effects of caffeine in neurodegenerative diseases.

Authors:  Mahshad Kolahdouzan; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2017-04       Impact factor: 5.243

5.  Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging.

Authors:  Barbara Shukitt-Hale; Marshall G Miller; Yi-Fang Chu; Barbara J Lyle; James A Joseph
Journal:  Age (Dordr)       Date:  2013-01-24

Review 6.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

7.  Coffee consumption and incident dementia.

Authors:  Saira Saeed Mirza; Henning Tiemeier; Renée F A G de Bruijn; Albert Hofman; Oscar H Franco; Jessica Kiefte-de Jong; Peter J Koudstaal; M Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2014-08-26       Impact factor: 8.082

Review 8.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  A J Carman; P A Dacks; R F Lane; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

9.  Caffeine and cognitive decline in elderly women at high vascular risk.

Authors:  Marie-Noël Vercambre; Claudine Berr; Karen Ritchie; Jae H Kang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.